During the Joint General Assembly of OSIRIS, TIER2, and iRISE, Dr. Tony Ross-Hellauer, Coordinator of the TIER2 project, offered a concise overview of TIER2’s core contributions and the benefits of the growing tri-consortium partnership.

Dr. Ross-Hellauer highlights TIER2’s major contributions to strengthening the evidence base for reproducibility reform, including the extensive joint scoping review conducted with OSIRIS. This foundational work now informs several outputs across the partnership, notably iRISE’s SOLES platform. He also points to TIER2’s eight pilots, which are testing new interventions, tools, and practices that will support researchers, funders, and publishers. The results will be released in the coming months.

The collaboration with OSIRIS and iRISE has created significant synergies, enabling shared methodologies, interoperable outputs, and a unified approach to addressing system-level challenges. Joint efforts on evidence synthesis and interventions for publishers and funders have strengthened the quality and cohesion of the projects’ outputs.

As TIER2 enters its final phase, the consortium is preparing to deliver new tools, services, and policy recommendations, designed in alignment with OSIRIS and iRISE to ensure coherent and lasting contributions to Europe’s reproducibility landscape.

These insights reflect the shared commitment of OSIRIS, TIER2, and iRISE to strengthening reproducibility and building a more open, trustworthy European research system. Further updates and materials from the partnership will continue to be shared as the projects advance toward their final milestones.